• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对HLA-E的单克隆抗体与未折叠的无β2微球蛋白重链所携带的表位结合。

Monoclonal antibodies to HLA-E bind epitopes carried by unfolded β2 m-free heavy chains.

作者信息

Tremante Elisa, Lo Monaco Elisa, Ingegnere Tiziano, Sampaoli Camilla, Fraioli Rocco, Giacomini Patrizio

机构信息

Laboratory of Immunology, Regina Elena National Cancer Institute, Rome, Italy.

出版信息

Eur J Immunol. 2015 Aug;45(8):2356-64. doi: 10.1002/eji.201545446. Epub 2015 Jun 5.

DOI:10.1002/eji.201545446
PMID:25982269
Abstract

Since HLA-E heavy chains accumulate free of their light β2 -microglobulin (β2 m) subunit, raising mAbs to folded HLA-E heterodimers has been difficult, and mAb characterization has been controversial. Herein, mAb W6/32 and 5 HLA-E-restricted mAbs (MEM-E/02, MEM-E/07, MEM-E/08, DT9, and 3D12) were tested on denatured, acid-treated, and natively folded (both β2 m-associated and β2 m-free) HLA-E molecules. Four distinct conformations were detected, including unusual, partially folded (and yet β2 m-free) heavy chains reactive with mAb DT9. In contrast with previous studies, epitope mapping and substitution scan on thousands of overlapping peptides printed on microchips revealed that mAbs MEM-E/02, MEM-E/07, and MEM-E/08 bind three distinct α1 and α2 domain epitopes. All three epitopes are linear since they span just 4-6 residues and are "hidden" in folded HLA-E heterodimers. They contain at least one HLA-E-specific residue that cannot be replaced by single substitutions with polymorphic HLA-A, HLA-B, HLA-C, HLA-F, and HLA-G residues. Finally, also the MEM-E/02 and 3D12 epitopes are spatially distinct. In summary, HLA-E-specific residues are dominantly immunogenic, but only when heavy chains are locally unfolded. Consequently, the available mAbs fail to selectively bind conformed HLA-E heterodimers, and HLA-E expression may have been inaccurately assessed in some previous oncology, reproductive immunology, virology, and transplantation studies.

摘要

由于HLA - E重链在没有轻链β2 -微球蛋白(β2m)亚基的情况下积累,因此制备针对折叠的HLA - E异二聚体的单克隆抗体一直很困难,并且单克隆抗体的表征也存在争议。在此,对单克隆抗体W6/32和5种HLA - E限制性单克隆抗体(MEM - E/02、MEM - E/07、MEM - E/08、DT9和3D12)在变性、酸处理和天然折叠(β2m相关和β2m游离)的HLA - E分子上进行了测试。检测到四种不同的构象,包括与单克隆抗体DT9反应的异常、部分折叠(且β2m游离)的重链。与先前的研究不同,对印在微芯片上的数千个重叠肽进行的表位作图和取代扫描显示,单克隆抗体MEM - E/02、MEM - E/07和MEM - E/08结合三个不同的α1和α2结构域表位。所有这三个表位都是线性的,因为它们仅跨越4 - 6个残基,并且在折叠的HLA - E异二聚体中是“隐藏”的。它们包含至少一个HLA - E特异性残基,该残基不能被多态性HLA - A、HLA - B、HLA - C、HLA - F和HLA - G残基的单取代所替代。最后,MEM - E/02和3D12表位在空间上也是不同的。总之,HLA - E特异性残基具有主要的免疫原性,但仅当重链局部未折叠时才具有。因此,现有的单克隆抗体不能选择性地结合构象化的HLA - E异二聚体,并且在一些先前的肿瘤学、生殖免疫学、病毒学和移植研究中,HLA - E的表达可能被不准确地评估。

相似文献

1
Monoclonal antibodies to HLA-E bind epitopes carried by unfolded β2 m-free heavy chains.针对HLA-E的单克隆抗体与未折叠的无β2微球蛋白重链所携带的表位结合。
Eur J Immunol. 2015 Aug;45(8):2356-64. doi: 10.1002/eji.201545446. Epub 2015 Jun 5.
2
Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.抗 HLA-E mAb 3D12 模拟 MEM-E/02 与 HLA-B 和 HLA-C 等位基因结合:网络工具验证了抗体识别的 HLA-E 免疫原性表位。
Mol Immunol. 2011 Jan;48(4):423-30. doi: 10.1016/j.molimm.2010.09.011. Epub 2010 Dec 9.
3
Gastric cancer progression may involve a shift in HLA-E profile from an intact heterodimer to β2-microglobulin-free monomer.胃癌的进展可能涉及 HLA-E 谱从完整异二聚体向β2-微球蛋白游离单体的转变。
Int J Cancer. 2014 Apr 1;134(7):1558-70. doi: 10.1002/ijc.28484. Epub 2013 Dec 11.
4
HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies.HLA-E 单克隆抗体识别经典 HLA Ⅰ类上的共享肽序列:与人类天然 HLA 抗体的相关性。
Mol Immunol. 2010 Feb;47(5):1121-31. doi: 10.1016/j.molimm.2009.10.024. Epub 2009 Nov 26.
5
The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex.泛 HLA I 类反应性单克隆抗体 W6/32 所识别的表位及其与 HLA - B27/β2 - 微球蛋白复合物异常稳定性的关系。
Immunogenetics. 2001 Aug;53(6):440-6. doi: 10.1007/s002510100353.
6
HLA-E: strong association with beta2-microglobulin and surface expression in the absence of HLA class I signal sequence-derived peptides.HLA-E:与β2-微球蛋白以及在缺乏HLA I类信号序列衍生肽情况下的表面表达密切相关。
J Immunol. 2008 Oct 15;181(8):5442-50. doi: 10.4049/jimmunol.181.8.5442.
7
Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains.单克隆抗体TP25.99在β2-微球蛋白相关及无β2-微球蛋白的HLA I类重链上识别的不同决定簇的结构相关性
J Immunol. 2000 Sep 15;165(6):3275-83. doi: 10.4049/jimmunol.165.6.3275.
8
Dissociation of beta 2-microglobulin from HLA class I heavy chains correlates with acquisition of epitopes in the cytoplasmic tail.β2-微球蛋白与HLA I类重链的解离与细胞质尾部表位的获得相关。
J Immunol. 1995 May 15;154(10):5205-15.
9
Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules.识别HLA-G或HLA-E的单克隆抗体的特性:分析非经典HLA I类分子表达的新工具。
Hum Immunol. 2003 Mar;64(3):315-26. doi: 10.1016/s0198-8859(02)00821-2.
10
Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.I类HLA折叠及β2-微球蛋白缺陷型Daudi细胞中的抗原呈递
J Immunol. 2009 Mar 15;182(6):3609-17. doi: 10.4049/jimmunol.0802316.

引用本文的文献

1
CD8 T cell targeting of tumor antigens presented by HLA-E.CD8 T 细胞靶向 HLA-E 呈递的肿瘤抗原。
Sci Adv. 2024 May 10;10(19):eadm7515. doi: 10.1126/sciadv.adm7515.
2
The antibodies 3D12 and 4D12 recognise distinct epitopes and conformations of HLA-E.抗体 3D12 和 4D12 识别 HLA-E 的不同表位和构象。
Front Immunol. 2024 Mar 20;15:1329032. doi: 10.3389/fimmu.2024.1329032. eCollection 2024.
3
HLA-C*04:09N is expressed at the cell surface and triggers peptide-specific T-cell activation.HLA-C*04:09N 表达于细胞表面,触发肽特异性 T 细胞激活。
Haematologica. 2024 Apr 1;109(4):1121-1127. doi: 10.3324/haematol.2023.283812.
4
Antibodies for β2-Microglobulin and the Heavy Chains of HLA-E, HLA-F, and HLA-G Reflect the HLA-Variants on Activated Immune Cells and Phases of Disease Progression in Rheumatoid Arthritis Patients under Treatment.β2微球蛋白以及HLA-E、HLA-F和HLA-G重链的抗体反映了接受治疗的类风湿关节炎患者活化免疫细胞上的HLA变体以及疾病进展阶段。
Antibodies (Basel). 2023 Mar 31;12(2):26. doi: 10.3390/antib12020026.
5
ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function.ERAP1 通过影响自然杀伤细胞功能控制抑制性受体 KIR3DL1 与 HLA-B51:01 的相互作用。
Front Immunol. 2021 Nov 30;12:778103. doi: 10.3389/fimmu.2021.778103. eCollection 2021.
6
Deregulation of HLA-I in cancer and its central importance for immunotherapy.肿瘤中 HLA-I 的失调及其对免疫治疗的核心重要性。
J Immunother Cancer. 2021 Aug;9(8). doi: 10.1136/jitc-2021-002899.
7
Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome by Pharmacological Inhibition of Cdc42-Induced Actin Cytoskeleton Remodeling.慢性淋巴细胞白血病细胞对 NK 细胞介导的裂解的固有抗性可以通过抑制 Cdc42 诱导的肌动蛋白细胞骨架重塑来克服。
Front Immunol. 2021 May 24;12:619069. doi: 10.3389/fimmu.2021.619069. eCollection 2021.
8
The Potential of Soluble Human Leukocyte Antigen Molecules for Early Cancer Detection and Therapeutic Vaccine Design.可溶性人类白细胞抗原分子在早期癌症检测及治疗性疫苗设计中的潜力
Vaccines (Basel). 2020 Dec 18;8(4):775. doi: 10.3390/vaccines8040775.
9
Enhancing Natural Killer and CD8 T Cell-Mediated Anticancer Cytotoxicity and Proliferation of CD8 T Cells with HLA-E Monospecific Monoclonal Antibodies.利用HLA-E单特异性单克隆抗体增强自然杀伤细胞和CD8 T细胞介导的抗癌细胞毒性以及CD8 T细胞的增殖
Monoclon Antib Immunodiagn Immunother. 2019 Apr;38(2):38-59. doi: 10.1089/mab.2018.0043.
10
Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity.细胞膜上HLA - C的稳定性和表达水平调节HIV - 1感染性。
J Virol. 2017 Dec 14;92(1). doi: 10.1128/JVI.01711-17. Print 2018 Jan 1.